Search
-
How platforms can boost social authenticity and engagement
Of all the metrics monitored by social media platforms, Snap’s Alex Dao thinks one is underconsidered: happiness. By blending AR and user creativity, platforms can produce new opportunities for it.
-
How AI evaluations will support smarter marketing spending
Human evaluation is the gold standard for creative testing, but comes with logistical challenges. AI-powered tools could help brands close that gap, says Ipsos’ Lisa Zielinski.
-
Why advertising will still need human creative directors
As partner and executive creative director at the influential ad agency Mischief, Bianca Guimaraes keeps a close eye on the future. She thinks AI has its uses — but it could also put a premium on human ingenuity.
-
How electric vehicle incentives can charge the market
What policymakers need to know about public opinion to create an equitable and accessible EV market across the country and in key states.
-
The Right Blend: A quick guide to ensuring high-quality B2B market research sample
Here’s the 5 things client-centric B2B companies should do to ensure they are making decisions with high-quality data.
-
Why panel-member first is good for research and business
The KnowledgePanel employs a highly effective approach to online probability research that emphasizes the experience and life cycle of panel members, something we call the Panel-Member First Approach.
-
Does AI have a halo with B2B buyers?
Here’s what marketers need to know about B2B buyers and users when positioning AI-powered software.
-
[RECORDING] The Patient Perspective: Evaluating Time and Treatment While Living with Metastatic Breast Cancer
Join us as breast cancer expert from Ipsos, Eric Blouin, and CEO of Living Beyond Breast Cancer, Jean Sachs, dive into the findings and implications of this research.
-
What Regulators Need to Know About Third-Party App Installers
If regulators want to create a competitive app installer market, consumers must be able to have a fast, easy download experience, while still feeling safe.
-
The Patient Perspective: Evaluating Time and Treatment While Living with Metastatic Breast Cancer
The results of this research demonstrate the time-burden on ER+, HER2- mBC patients and their loved ones when going to receive care and the potential difficulty of care when an IM injection is part of their treatment plan.